5 Key Sessions, Interviews at Asembia AXS23 Summit

Pharmacy Times will be attending the Asembia AXS23 Summit, happening in Las Vegas, Nevada, from April 30 to May 4.

The conference features an array of speakers, networking events, and continuing education sessions for pharmacists, pharmacy staff and stakeholders, with a focus on building business relationships that impact prescription fulfillment and delivery for patients. The meeting promises more than 6000 attendees, 1000 organizations represented, and 200 exhibitors and sponsors.

Stay tuned on PharmacyTimes.com for exclusive session coverage and interviews with experts, including:

• A review of the 2023 specialty therapy pipeline and analysis of key drugs and biologics in development. Presenter Ray Tancredi, MBA, divisional vice president of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, will cover the latest FDA specialty approvals as well as key drugs in the pipeline.
• A conversation with Elizabeth Johnson, a presenter in the session titled “Trust v. Healthcare: How Empathy Is the Missing Link in Drug Development, Marketing, and Delivery.” With the COVID-19 pandemic revealing the importance of patient trust in health care, 4 experts will tackle the need for empathy when building trust with patients.
• A session discussing the current biosimilars landscape, presented by Juliana Reed, MS, executive director of the Biosimilars Forum. Reed’s session will cover the current state of the biosimilars market, its outlook for the second half of 2023, and the impact of biosimilar access for patients, providers, and employers.
• An interview with Connie Sullivan, president and CEO of the National Home Infusion Association, on her session titled “Leveraging the Home Site of Care for Infused Specialty Medication.” Sullivan will discuss the benefits of home infusions, the role of the pharmacist in this environment, and reimbursement considerations.
• A discussion with experts Nick Meza, attorney and partner at Quarles & Brady LLP, and David Skomo, chief operating officer of HealthDyne, about the changing landscape of legislation affecting specialty pharmacy. Expanding nonresident pharmacy laws and regulations are making this a particularly complicated area, and Meza and Skomo’s session aims to review challenges and solutions for the specialty pharmacy operational model.

Follow Pharmacy Times’ website and social media for all of the latest updates and coverage.